JG
JANX icon

Jain Global’s Janux Therapeutics JANX Stock Holding History

Jain Global’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
41,429
+19,969
+93% +$289K ﹤0.01% 1130
2026
Q1 		$298K Buy
+21,460
New +$294K ﹤0.01% 1023
2025
Q4 		– Sell
-9,844
Closed -$241K – 1369
2025
Q3 		$241K Buy
+9,844
New +$240K ﹤0.01% 862

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Jain Global's JANX Position: Q2 2026 in Review

Jain Global increased its Janux Therapeutics (JANX) stake by 93% in Q2 2026, buying an estimated $289K and bringing the position to 41,429 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #1130.

Jain Global first reported a position in JANX in Q3 2025 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Jain Global held 41,429 shares of Janux Therapeutics worth $636K as of Q2 2026.
  • Jain Global bought 19,969 Janux Therapeutics shares in Q2 2026, an estimated $289K.
  • Janux Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1130 holding.
  • Jain Global first reported a position in Janux Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.